| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Folate metabolism 0.7584818988875188 2.409556799283306 0.0159719097071486 0.9999286415883362 0.3507904613458951 14 P34896,P00374,P34897,Q8WTV0 4 |
| Alzheimers disease 0.4598306446870232 2.184027923269257 0.0289601962746302 0.9999999729877854 0.4734568391111276 80 P49720,P21796,P20618,P49721,P45880,P28070,P28072 7 |
| Proteasome degradation 0.5471409436754703 2.1761887223495715 0.029541151850104 0.999999981057619 0.4734568391111276 41 P49720,O75832,Q99436,P20618,P49721,P10321,P28070,P60900,P28072 9 |
| Alzheimers disease and mirna effects 0.4544404559080193 2.141475344454832 0.032235724687212 0.9999999963577928 0.4791803415533908 82 P49720,P21796,P20618,P49721,P45880,P28070,P28072 7 |
| Fluoropyrimidine activity 0.7229232597540715 2.1304980982274975 0.0331305126537757 0.9999999978955532 0.4791803415533908 12 Q92820,Q99808,P00374,P31350 4 |
| Sphingolipid metabolism overview 0.8365662894736476 2.0603085279738327 0.0393690551782965 0.9999999999547052 0.5429267376913924 7 O95470,Q06136,Q13510,Q16739,O15270 5 |
| Sphingolipid metabolism integrated pathway 0.8365662894736476 2.0603085279738327 0.0393690551782965 0.9999999999547052 0.5429267376913924 7 O95470,Q06136,Q13510,Q16739,O15270 5 |
| Glycosaminoglycan degradation 0.8214093921065865 2.0037749343663007 0.0450941750404418 0.999999999998692 0.5823538798061927 6 P54802,P15586,P06865,P08236 4 |
| Sphingolipid pathway 0.7269192302436069 1.9659122590468203 0.0493087467349779 0.9999999999999052 0.5823538798061927 10 O95470,Q06136,Q13510,Q16739,O15270 5 |
| Serine metabolism 0.8101291632231241 1.9579360164458977 0.0502375210410144 0.9999999999999468 0.5823538798061927 6 P34896,P00374,P34897 3 |
| Sphingolipid metabolism in senescence 0.6860364884472128 1.9523780975174223 0.0508933314558364 0.9999999999999648 0.5823538798061927 12 P06400,P16278,Q06136,Q13510,Q16739,Q96G23 6 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.7081962456416109 1.88014650873347 0.0600881134169459 1.0 0.6169323533376858 10 Q96AY3,O75718,Q32P28 3 |
| Transsulfuration and onecarbon metabolism 0.5878640889495196 1.8134529926389065 0.0697619825447566 1.0 0.6797407968238575 19 P34896,P00374,P34897 3 |
| Adipogenesis 0.6487011144443946 1.8115580763111911 0.0700545077384644 1.0 0.6797407968238575 13 O75844,P43490,P14174,P06400 4 |
| Disorders of folate metabolism and transport 0.7724593968804326 1.7990674252463326 0.0720080157152236 1.0 0.6797407968238575 7 P00374 1 |
| Ethanol effects on histone modifications 0.736175595024619 1.7606646577426253 0.0782951779425875 1.0 0.6797407968238575 8 Q9H9T3,P00374 2 |
| Metapathway biotransformation phase i and ii 0.566591394447599 1.7383977362889054 0.0821407553037449 1.0 0.6797407968238575 20 Q16850,P07099,P34913 3 |
| Vitamin b12 metabolism 0.7560601424261478 1.7351565616003055 0.0827130781213945 1.0 0.6797407968238575 6 P34897,Q8WTV0 2 |
| 7oxoc and 7betahc pathways 0.7023554535630497 1.72973271530246 0.0836780407557193 1.0 0.6797407968238575 9 O14975,P61916,P34913 3 |
| Nephrotic syndrome 0.6536019976717197 1.7053898677980788 0.0881217367728277 1.0 0.6843271156057633 11 O75844,Q9NQW6 2 |
| Inclusion body myositis 0.9337372207497197 1.6837304329111296 0.0922337770724626 1.0 0.6843271156057633 2 P05067 1 |
| Familial partial lipodystrophy fpld 0.7446907345258438 1.6836852513450973 0.0922425131541637 1.0 0.6843271156057633 7 O75844 1 |
| Camkk2 pathway 0.64891072691757 1.682631125088015 0.0924465224375028 1.0 0.6843271156057633 11 P09601,Q9Y3D6,Q14012,Q13501 4 |
| Onecarbon metabolism 0.612683881006957 1.6717066684387458 0.0945821785522444 1.0 0.6843271156057633 14 P00374,P34897 2 |
| Nucleotide metabolism 0.6167911440670542 1.6080619324340488 0.1078216154356996 1.0 0.7150961096749248 12 P00374,P31350 2 |
| Ketogenesis and ketolysis 0.8568782774810302 1.517558538297077 0.1291257257940761 1.0 0.7234944722781377 4 O43772 1 |
| Nanomaterial induced apoptosis 0.9444721024966324 1.5139221165866468 0.1300455940159204 1.0 0.7234944722781377 3 O95831 1 |
| Ebola virus infection in host 0.4884400862577238 1.5100451509147608 0.1310319035967133 1.0 0.7234944722781377 34 Q9UN37,P52294,Q99816,P12814,P10321,Q07021,O15118,P04439,P07858,P61916 10 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.8541532344812495 1.5071731592169515 0.1317662782563893 1.0 0.7234944722781377 4 P09601 1 |
| Pathways of nucleic acid metabolism and innate immune sensing 0.7329426470892878 1.4512952431266346 0.1466976653209593 1.0 0.7502495917418044 5 O00584,Q7Z434 2 |
| Metabolism of spingolipids in er and golgi apparatus 0.8351846363197131 1.4347769373186865 0.1513506718789585 1.0 0.7502495917418044 4 O95470,Q06136 2 |
| Disruption of postsynaptic signaling by cnv 0.6837411859188921 1.4301396774692003 0.1526769343721001 1.0 0.7502495917418044 6 Q07157,Q13555,Q06787 3 |
| Complement system in neuronal development and plasticity 0.7164272195279778 1.3833928715444817 0.1665444351107423 1.0 0.7502495917418044 5 Q9NR28 1 |
| Notch signaling pathway 0.6480039976089083 1.374253062635988 0.169363132542879 1.0 0.7502495917418044 8 P40763,Q96T58,Q13573,Q92542,P63208 5 |
| Cholesterol biosynthesis with skeletal dysplasias 0.6696106487097804 1.369796815518462 0.1707503364160685 1.0 0.7502495917418044 6 Q15392 1 |
| Influence of laminopathies on wnt signaling 0.6189603400330149 1.3485494408705967 0.1774817295874504 1.0 0.7502495917418044 9 O75844,P50402 2 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.6626339110008903 1.3361075428328744 0.1815141249423457 1.0 0.7502495917418044 7 O95140,Q9NR77 2 |
| Allograft rejection 0.6102921088787494 1.308302179045422 0.1907708363501246 1.0 0.7801869376249922 9 P01889,Q9BY49,P08183,P10321,P04439 5 |
| Oxysterols derived from cholesterol 0.6476230837123412 1.2717093036341462 0.2034764237580131 1.0 0.8208266618265426 7 P34913 1 |
| Cytosine methylation 0.6858779345382715 1.2573861375506303 0.2086138464489129 1.0 0.825541526758597 5 P48735 1 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.6833789747242421 1.2470649730618637 0.2123736749307379 1.0 0.825541526758597 5 P48506,P09601,O15111 3 |
| Tryptophan metabolism 0.536986138554681 1.2291084695694303 0.2190311400682072 1.0 0.8271919705341438 13 Q15392 1 |
| Pyrimidine metabolism 0.4379227539682347 1.2168936161857418 0.2236446948185433 1.0 0.8271919705341438 38 P31350,Q9NR33,Q9H773,P19387,P04818,Q9Y5B8,Q9BUI4 7 |
| Dna mismatch repair 0.4884737917992583 1.2077843816194616 0.2271302106006549 1.0 0.8271919705341438 19 Q9UQ84 1 |
| Calcium regulation in cardiac cells 0.4747553694070853 1.2071531418799732 0.2273731723390648 1.0 0.8271919705341438 21 P10644,Q13555,P05026,P62942,P0DP25,Q14012 6 |
| Interactions between loxl4 and oxidative stress pathway 0.8129496402877667 1.1898296137526123 0.2341133676163067 1.0 0.84138925452406 2 Q16543 1 |
| Nocgmppkg mediated neuroprotection 0.6232358190505691 1.166795700752724 0.243292883640936 1.0 0.8591722734307933 7 Q13555 1 |
| Tumor suppressor activity of smarcb1 0.52855113801083 1.153498782306769 0.2487057170833841 1.0 0.8591722734307933 12 O14497,Q12824,P06400,Q969G3 4 |
| Circadian rhythm genes 0.4370413567687015 1.1403231936717226 0.2541516784106852 1.0 0.8591722734307933 35 P04818,P43490,P54802,Q03164,P63208,Q9BWF3,Q9Y2W1,P11802,Q14103 9 |
| Cytosolic dnasensing pathway 0.595277911842453 1.1385288352493357 0.2548997253120251 1.0 0.8591722734307933 8 O14802,Q9BUI4,Q7Z434,O15111 4 |
| Glucocorticoid receptor pathway 0.6146322775403115 1.1337698170881387 0.256891114848184 1.0 0.8591722734307933 6 P27105 1 |
| Reninangiotensinaldosterone system raas 0.8390151515151554 1.12710971532195 0.2596960962065475 1.0 0.8591722734307933 3 Q13555,Q14012 2 |
| Novel intracellular components of rigilike receptor rlr pathway 0.5690020301480727 1.1156204153463696 0.2645846495692003 1.0 0.8591722734307933 9 O00571,Q13573,Q7Z434,Q92841,O15111 5 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.4705863488382633 1.0960406468673147 0.2730609868998512 1.0 0.863052900972858 19 Q15392,Q03426,Q9BWD1 3 |
| Cancer immunotherapy by pd1 blockade 0.8299955843319299 1.0943001012760865 0.273823380912976 1.0 0.863052900972858 3 P04439 1 |
| Cell migration and invasion through p75ntr 0.6441269852671334 1.0850175325797944 0.2779138901045073 1.0 0.863052900972858 5 P40763,O75962 2 |
| Apoptosis modulation and signaling 0.5412798187401087 1.0835124600829324 0.2785810233000805 1.0 0.863052900972858 10 O95831 1 |
| Tgfbeta receptor signaling in skeletal dysplasias 0.7419034115349906 1.078316741969542 0.2808924281412506 1.0 0.863052900972858 4 P62942 1 |
| Tgfbeta receptor signaling 0.7419034115349906 1.078316741969542 0.2808924281412506 1.0 0.863052900972858 4 P62942 1 |
| Mitochondrial complex i assembly model oxphos system 0.4592718169414744 1.063118019345457 0.2877284337692714 1.0 0.865296773385443 20 O75306,Q96CU9 2 |
| Fragile x syndrome 0.4287067121528579 1.0563142393635565 0.2908246725695165 1.0 0.865296773385443 34 P05067,P62993,Q14012,P53985,Q06787 5 |
| Retinoblastoma gene in cancer 0.3916737914637324 1.0489052082305252 0.2942217482192764 1.0 0.865296773385443 47 Q9NQW6,P00374,Q9Y619 3 |
| Progeriaassociated lipodystrophy 0.5537832524404025 1.0444000219014526 0.2963003534996093 1.0 0.865296773385443 9 O75844 1 |
| Il10 antiinflammatory signaling pathway 0.7301778840832396 1.033827216318087 0.3012169457361144 1.0 0.865296773385443 4 P09601 1 |
| Mitochondrial long chain fatty acid betaoxidation 0.5047129929174488 1.0289343959208557 0.3035105039867996 1.0 0.865296773385443 12 O43772,Q16836 2 |
| Gdnfret signaling axis 0.8074746860998696 1.0128241766191892 0.3111441505449666 1.0 0.8734929703498009 3 O94813 1 |
| Monoamine transport 0.760696705793267 0.9800214097169246 0.3270755505235989 1.0 0.8734929703498009 2 O15127 1 |
| 15q112 copy number variation syndrome 0.7158252794688922 0.979607761196096 0.3272797723864482 1.0 0.8734929703498009 4 Q06787 1 |
| Selenium micronutrient network 0.4950699331882319 0.9785215357185422 0.3278164453772745 1.0 0.8734929703498009 12 Q8WTV0 1 |
| Leptininsulin signaling overlap 0.7599394168875391 0.977023908198831 0.3285573162703681 1.0 0.8734929703498009 2 P40763 1 |
| Interferon type i signaling pathways 0.4780585442036388 0.9756524291144032 0.3292367336213062 1.0 0.8734929703498009 15 P40763,P46108,P22681,Q53EL6,P23588 5 |
| Glycogen synthesis and degradation 0.4758405819741024 0.9631684604177424 0.33546299011181 1.0 0.8734929703498009 15 P30153,P0DP25,P30154,P46020,P63151 5 |
| Network map of sarscov2 signaling pathway 0.4325651365726261 0.9366452914586332 0.3489410463452178 1.0 0.8802674434627911 22 P31350,Q08380,Q07021,Q7Z434,P07858 5 |
| Mevalonate pathway 0.6966108733638462 0.9075504044504644 0.3641158075298889 1.0 0.886465748402464 4 Q9BWD1 1 |
| Preimplantation embryo 0.5428979869946907 0.9038777206647352 0.3660602440659013 1.0 0.886465748402464 8 Q99729,Q92945 2 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.6947522837862767 0.9006185795991332 0.3677911525166126 1.0 0.886465748402464 4 Q03252,O60725 2 |
| Ras signaling 0.427451544693887 0.8960022642902933 0.3702515539072095 1.0 0.886465748402464 21 Q7Z569,P62993 2 |
| Oxidative phosphorylation 0.4187676658766647 0.8884613988424818 0.3742926109413609 1.0 0.886465748402464 27 P00846,O75306,O43674,O75787,Q15904,O75964 6 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.4873569025901073 0.8761590980155164 0.3809435487401842 1.0 0.886465748402464 11 Q13153,P62993,P49841,P22681,Q9UHD1,P11802 6 |
| Tlr4 signaling and tolerance 0.734191594093153 0.876123657102273 0.3809628132336495 1.0 0.886465748402464 2 Q15629 1 |
| Fatty acid betaoxidation 0.4469380713416909 0.8721185670964532 0.3831436980728724 1.0 0.886465748402464 17 O43772,Q16836 2 |
| Il3 signaling pathway 0.5140190495596879 0.8588259237542182 0.3904365628761164 1.0 0.886465748402464 9 P40763,P46109,P22681,P62993 4 |
| Wnt signaling pathway and pluripotency 0.4661959812908758 0.8507566014323615 0.3949045739920351 1.0 0.886465748402464 13 P63151,P30154 2 |
| Erbb signaling pathway 0.4612709280414842 0.8506874913568196 0.3949429735204386 1.0 0.886465748402464 14 Q13555,P46108,P62993,P46109,P49841,P22681 6 |
| Pregnane x receptor pathway 0.6780472673709531 0.8386743542416162 0.4016520734572348 1.0 0.886465748402464 4 P08183,P07900 2 |
| Hepatitis b infection 0.4335573907263786 0.8341332629501185 0.4042058929515821 1.0 0.886465748402464 18 P40763,O00571,P62993,P31946,Q7Z434,Q15904,O15111 7 |
| Tnfalpha signaling pathway 0.4512236414020282 0.8249168015861744 0.4094188268095275 1.0 0.886465748402464 15 Q16543,Q9NR28,P62993 3 |
| Ncrnas involved in stat3 signaling in hepatocellular carcinoma 0.7171525937145028 0.8106281459560961 0.4175792483732208 1.0 0.886465748402464 2 P40763 1 |
| Altered glycosylation of muc1 in tumor microenvironment 0.717152593714502 0.8106281459560927 0.4175792483732228 1.0 0.886465748402464 2 O15111 1 |
| Photodynamic therapyinduced nfkb survival signaling 0.717152593714502 0.8106281459560927 0.4175792483732228 1.0 0.886465748402464 2 O15111 1 |
| Sting pathway in kawasakilike disease and covid19 0.717152593714502 0.8106281459560927 0.4175792483732228 1.0 0.886465748402464 2 O15111 1 |
| Canonical nfkb pathway 0.717152593714502 0.8106281459560927 0.4175792483732228 1.0 0.886465748402464 2 O15111 1 |
| Fibrin complement receptor 3 signaling pathway 0.717152593714502 0.8106281459560927 0.4175792483732228 1.0 0.886465748402464 2 O15111 1 |
| Mirnas involvement in the immune response in sepsis 0.717152593714502 0.8106281459560927 0.4175792483732228 1.0 0.886465748402464 2 O15111 1 |
| Vitamin d in inflammatory diseases 0.717152593714502 0.8106281459560927 0.4175792483732228 1.0 0.886465748402464 2 O15111 1 |
| Nodlike receptor nlr signaling pathway 0.717152593714502 0.8106281459560927 0.4175792483732228 1.0 0.886465748402464 2 O15111 1 |
| Pyrimidine metabolism and related diseases 0.5358252793971321 0.7975200256140833 0.4251490772418735 1.0 0.886465748402464 6 P31350 1 |
| Aryl hydrocarbon receptor pathway wp2873 0.6632801285094978 0.7845357239372313 0.4327258286472619 1.0 0.886465748402464 4 Q16543 1 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.5318427921869153 0.7755903755423271 0.4379908848800229 1.0 0.886465748402464 7 Q9BWD1 1 |
| Hepatitis c and hepatocellular carcinoma 0.5131438301088521 0.7720021318845843 0.4401131648364151 1.0 0.886465748402464 8 P40763,P31350,P62993 3 |
| Il4 signaling pathway 0.4932737652793484 0.7629354652211211 0.4455018841123095 1.0 0.8883076064271238 9 P22681,P62993 2 |
| Proximal tubule transport 0.4653296382024952 0.7144880034720517 0.4749254716796967 1.0 0.923379687560853 10 Q9Y5K8,P05026,P08183,P38606,P36543 5 |
| Onecarbon metabolism and related pathways 0.4174849202079137 0.6143294887325372 0.5389976198755981 1.0 0.9778597138282412 14 P34897,P34896,P32929,P04818,P48506 5 |
| Degradation pathway of sphingolipids including diseases 0.4920634105199059 0.6108666440080748 0.5412878689224327 1.0 0.9778597138282412 7 P06280,P06865 2 |
| Burn wound healing 0.4914061769694979 0.6082009003152785 0.543054237573291 1.0 0.9778597138282412 7 Q99439 1 |
| Embryonic stem cell pluripotency pathways 0.4411991403889523 0.6002158615105843 0.5483623840847724 1.0 0.9778597138282412 10 P40763,P61160,P62993 3 |
| Photodynamic therapyinduced hif1 survival signaling 0.440548383144408 0.5971720037874562 0.5503925487101113 1.0 0.9778597138282412 10 P53985 1 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.412660385693443 0.5701051405696989 0.5686063887826109 1.0 0.9813377843915352 13 O75844,P06400,O60725,P50402,P11802,P55209 6 |
| Pdgfrbeta pathway 0.4774106695065136 0.5588484773859377 0.5762651347026961 1.0 0.9813377843915352 6 P62993 1 |
| Physicochemical features and toxicityassociated pathways 0.3983790722250736 0.558571926916611 0.5764539035872396 1.0 0.9813377843915352 16 P35080,P62993,Q14012,P22681,P07196 5 |
| Myometrial relaxation and contraction pathways 0.3981035269805255 0.5570442313439238 0.5774972091435215 1.0 0.9813377843915352 16 P10644,Q13555,Q99439 3 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.6696969696969755 0.543790054108043 0.5865859537863147 1.0 0.9813377843915352 3 P48729,P49841 2 |
| Tcell receptor tcr signaling pathway 0.3921778961727778 0.524328196653567 0.6000502884695416 1.0 0.9871294061449704 16 P46108,Q13153,P08670,P62993,P46109,P22681,Q9UJU6,O15111 8 |
| Hepatocyte growth factor receptor signaling 0.4338486739103943 0.4970854261786955 0.6191288113912661 1.0 0.9871294061449704 9 P40763,P46109,P46108,P62993 4 |
| Familial hyperlipidemia type 4 0.6270352139341231 0.4904928214557443 0.6237852082969466 1.0 0.9871294061449704 2 Q9UBV2 1 |
| Liver x receptor pathway 0.6270352139341098 0.4904928214557022 0.6237852082969764 1.0 0.9871294061449704 2 O00767 1 |
| Ciliopathies 0.3786517298615962 0.4755459281636131 0.6343979053970503 1.0 0.9871294061449704 17 O43924,Q9BW83,Q15555,Q9Y5B8,Q2M1P5 5 |
| Met in type 1 papillary renal cell carcinoma 0.3775525895453127 0.4694077499586032 0.6387782098643262 1.0 0.9871294061449704 17 P40763,P46108,P62993,P46109,P22681,Q92733 6 |
| Thermogenesis 0.359206902099494 0.4547444540284519 0.649293095525804 1.0 0.9871294061449704 21 Q12824,Q969G3,P62993,O14497,O43772 5 |
| Mrna processing 0.3053733376283853 0.4494692001148274 0.6530932216121283 1.0 0.9871294061449704 91 P55795,Q15428,P52756,O43390,P31943,P61978,Q01130,Q14103,P67809,Q5KU26,Q9UKA9,P07910,O75533,Q14562,O75937,P35637,Q99729,P38159,P22626,O75400 20 |
| Neural crest cell migration in cancer 0.4282795585409625 0.4150802498578241 0.6780831570402883 1.0 1.0 8 Q99523,P40763,O75962 3 |
| Il9 signaling pathway 0.4667686434155742 0.3982800879843828 0.6904237364845993 1.0 1.0 5 P62993 1 |
| Proteoglycan biosynthesis 0.5963650132525591 0.3959759109791308 0.6921227991099228 1.0 1.0 2 Q8TB61 1 |
| Il2 signaling pathway 0.4092619103248648 0.3936742514578451 0.6938215537745571 1.0 1.0 9 P40763,P22681,P62993 3 |
| Spinal cord injury 0.3608977140762234 0.3779873582043409 0.7054399852169344 1.0 1.0 17 O94813,P06400,P62942,P14174,P17931,P11802 6 |
| Praderwilli and angelman syndrome 0.416741175546477 0.3342539819521217 0.738187912378673 1.0 1.0 6 Q7L576,P06400 2 |
| Neuroinflammation and glutamatergic signaling 0.3521539741629089 0.3313687065706595 0.740365999429005 1.0 1.0 17 Q13555,P34897 2 |
| Ebsteinbarr virus lmp1 signaling 0.4417535287374581 0.3173301582401791 0.750993096007752 1.0 1.0 5 Q9NR12,P07900,O15111 3 |
| Biomarkers for pyrimidine metabolism disorders 0.4111308082101027 0.3152831469146576 0.7525466797911227 1.0 1.0 6 P31350 1 |
| Constitutive androstane receptor pathway 0.4354049517521381 0.2978690582787232 0.7658031044726072 1.0 1.0 5 P08183,P07900 2 |
| Supression of hmgb1 mediated inflammation by thbd 0.5809919753432813 0.2972339968992481 0.7662878683060876 1.0 1.0 3 O15111 1 |
| Vitamin d receptor pathway 0.3648202933794913 0.2941826529045111 0.7686183354401308 1.0 1.0 11 Q92783,Q99626,Q92604,P08183,P49427 5 |
| Melanoma 0.3565153681650349 0.2905894150924398 0.7713653564420406 1.0 1.0 12 P06400,P0DP25,P62993 3 |
| Epo receptor signaling 0.4006620526058465 0.2808852898174582 0.7787983836625594 1.0 1.0 6 P62993 1 |
| Nonsmall cell lung cancer 0.3609760093739785 0.2780674340364625 0.7809605941198825 1.0 1.0 11 P40763,P06400,P62993 3 |
| Sarscov2 innate immunity evasion and cellspecific immune response 0.3629062114210458 0.2584243635219178 0.7960794156508029 1.0 1.0 10 P35613 1 |
| Hijack of ubiquitination by sarscov2 0.4204476479746883 0.253932057845264 0.799548047746621 1.0 1.0 5 Q13564,Q8TBC4 2 |
| Aryl hydrocarbon receptor pathway wp2586 0.36658246497869 0.2292656381280776 0.8186624590173885 1.0 1.0 9 P48506,P06400,P07900,Q16543 4 |
| Ferroptosis 0.321929624122912 0.2274252929547596 0.8200930545815439 1.0 1.0 22 P45880 1 |
| Pparalpha pathway 0.409386344797383 0.2232759143537615 0.8233207716824595 1.0 1.0 5 P23786 1 |
| Complement and coagulation cascades 0.5232866338508121 0.2132176611798045 0.8311571933596262 1.0 1.0 2 P49257 1 |
| Head and neck squamous cell carcinoma 0.3364019886201964 0.2088816876814888 0.8345405999484514 1.0 1.0 13 P62942,P06400 2 |
| Neural crest cell migration during development 0.3809732890201748 0.2081613002380758 0.8351030246173092 1.0 1.0 7 P40763,O75962 2 |
| Cohesin complex cornelia de lange syndrome 0.3343593356413536 0.2057312087965661 0.8370008788990475 1.0 1.0 14 P30154 1 |
| Sudden infant death syndrome sids susceptibility pathways 0.312887645466347 0.1819327031738872 0.8556355393484449 1.0 1.0 21 P12235,P10644,P42892,P31946,P04075,P67809 6 |
| Cysteine and methionine catabolism 0.3654722931682651 0.1630996550319563 0.8704399714050177 1.0 1.0 7 P48506,P32929 2 |
| Mfap5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement 0.3793268959265128 0.1485736082883609 0.8818900993732222 1.0 1.0 5 Q07157 1 |
| Ccl18 signaling pathway 0.343417601020724 0.1245503198217576 0.9008795610566084 1.0 1.0 8 P07196 1 |
| Hedgehog signaling pathway wp4249 0.4890550124415525 0.1215291260620375 0.9032719464100324 1.0 1.0 3 Q2M1P5 1 |
| Eicosanoid synthesis 0.4680045437334337 0.1209306325915625 0.9037459789200846 1.0 1.0 2 Q9H7Z7 1 |
| Mitochondrial immune response to sarscov2 0.3451652876770342 0.1096839162705298 0.9126600564031992 1.0 1.0 7 Q7Z434,Q9BQ95 2 |
| Pathways affected in adenoid cystic carcinoma 0.3084760784211328 0.0998989199279158 0.9204245738356064 1.0 1.0 12 O14497,Q969G3 2 |
| Mecp2 and associated rett syndrome 0.3073312489187531 0.0988480261302603 0.9212589358474528 1.0 1.0 15 P52597,P35637 2 |
| Eukaryotic transcription initiation 0.3295010852977745 0.0872385690119609 0.930481882567137 1.0 1.0 8 P18074,P19387,O95602 3 |
| Modulators of tcr signaling and t cell activation 0.304347174818845 0.0856511499552765 0.9317437360381722 1.0 1.0 12 P62993 1 |
| Histone modifications 0.4074828963897151 0.0829145214078841 0.933919507387284 1.0 1.0 4 Q03164 1 |
| Pdgf pathway 0.3036997861966376 0.0818447619050792 0.9347701605964924 1.0 1.0 13 P53365,P62993 2 |
| Signal transduction through il1r 0.4065231125178007 0.0816008020974267 0.9349641634421576 1.0 1.0 4 Q9BQ95,O15111 2 |
| Il6 signaling pathway 0.3193597379422413 0.0788789413518944 0.9371289134093468 1.0 1.0 9 P62993 1 |
| Epithelial to mesenchymal transition in colorectal cancer 0.3010399311554418 0.0788547270772715 0.9371481736129628 1.0 1.0 16 Q16625 1 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.3769059812787673 0.0465935557602938 0.9628371682122788 1.0 1.0 4 Q7Z434 1 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.3020444239966033 0.0365958512932383 0.9708072515046264 1.0 1.0 6 P49770,P49841 2 |
| Mbdnf and probdnf regulation of gaba neurotransmission 0.3104733947180331 0.0292945817614298 0.9766296481774648 1.0 1.0 5 P40763 1 |
| Methylation pathways 0.3723484848484995 0.0252207693838544 0.9798788706518292 1.0 1.0 3 P21964,Q9NZL9 2 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.3002274450341081 0.0177003520320645 0.9858778998114834 1.0 1.0 5 P06730,P18031,P06753,O15111 4 |
| G protein signaling pathways 0.2853646359591569 0.0143560712206711 0.9885459058625798 1.0 1.0 11 P10644,Q92667 2 |
| Il17 signaling pathway 0.3340098716922774 0.0131811653243815 0.989483256230479 1.0 1.0 4 P40763,P49841 2 |
| Ranklrank signaling pathway 0.2826460248396308 0.0129304625504355 0.9896832710552196 1.0 1.0 13 Q13501 1 |
| Pi3kakt signaling pathway 0.2846370835857039 0.0051356639683685 0.9959023510227872 1.0 1.0 29 P30153,P08238,P07900,P14625,P62993,P30154,P49841,P63151,P11802,P23588,Q16543,O15111 12 |
| T cell receptor and costimulatory signaling 0.3160287987874246 0.0042534882169401 0.9966062176556264 1.0 1.0 4 P48729,P49841,P19174 3 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.3160287987874237 0.0042534882169396 0.9966062176556268 1.0 1.0 4 P42345,P49841,Q15382 3 |
| Bladder cancer 0.2828101065629131 0.0013043963521337 0.9989592425845976 1.0 1.0 5 P06400 1 |
| Nitric oxide metabolism in cystic fibrosis 0.3057976506252391 0.0002625453330705 0.9997905191346388 1.0 1.0 4 Q86X55,O14744,Q99873 3 |
|
|
